Lassalle P, Delneste Y, Gosset P, Gras-Masse H, Wallaert B, Tonnel A B
Contrat Jeune Formation (INSERM 90-06), Institut Pasteur, Lille, France.
Eur J Immunol. 1993 Apr;23(4):796-803. doi: 10.1002/eji.1830230404.
Current concepts on the pathogenesis of chronic asthma emphasize the role of several inflammatory cell populations and their respective mediators that interact in a complex network. However, beside inflammatory cells, lymphocytes are also present in asthmatic airways. Although little is known about their involvement in asthma, it has been suggested that lymphocytes may participate in the development of chronic inflammation either through lymphokine secretion or through antibody production. In this study, we describe circulating IgG autoantibodies, directed against a common 55-kDa antigen shared by platelets and cultured endothelial cells, and found in 34 out of 97 asthmatic patients. Among epidemiological, clinical and biological characteristics of these asthmatic patients, the anti-55-kDa antigen antibodies are mainly restricted to patients with negative cutaneous prick tests (p = 0.0014), and corticosteroid-dependent asthma (p = 0.0036). These antibodies were also detected in a few patients with autoimmune disorders like systemic lupus erythematosus (3/30) or rheumatoid arthritis (2/36). Both platelet and endothelial cell antigens were cross-reactive, had an isoelectric point between 8.0 and 9.0, were insensitive to reducing agents such as 2-mercaptoethanol, and were not present on either platelet or endothelial cell surface, as determined by immunostaining assay. [3H]Thymidine incorporation assay with peripheral blood mononuclear cells from patients in the presence or in the absence of 55-kDa antigen, purified from nitrocellulose sheets demonstrated a specific incorporation in 6 out of 13 patients with circulating anti-55-kDa antigen antibodies, with index values ranging from 12 to 3. Such a T cell reactivity has also been observed in 3 out to 17 patients without detectable serum anti-55-kDa antigen antibodies. Moreover, a significant correlation was found between index values of antigen-specific T cell reactivity and the forced expiratory volume in one second (r = 0.544, p = 0.003). Our data indicate that the detection of such antibodies allows to distinguish a subgroup of asthmatics in terms of severity and to suggest a relationship between clinical severity and T and B cell autoreactivity to the 55-kDa platelet/endothelial cell antigen.
目前关于慢性哮喘发病机制的概念强调了几种炎症细胞群体及其各自介质在复杂网络中相互作用的作用。然而,除了炎症细胞外,淋巴细胞也存在于哮喘气道中。尽管对它们在哮喘中的作用了解甚少,但有人认为淋巴细胞可能通过淋巴因子分泌或抗体产生参与慢性炎症的发展。在本研究中,我们描述了循环中的IgG自身抗体,其针对血小板和培养的内皮细胞共有的一种常见的55 kDa抗原,在97例哮喘患者中有34例被发现。在这些哮喘患者的流行病学、临床和生物学特征中,抗55 kDa抗原抗体主要局限于皮肤点刺试验阴性的患者(p = 0.0014)和依赖皮质类固醇的哮喘患者(p = 0.0036)。在一些自身免疫性疾病患者中也检测到了这些抗体,如系统性红斑狼疮(3/30)或类风湿关节炎(2/36)。通过免疫染色分析确定,血小板和内皮细胞抗原均具有交叉反应性,其等电点在8.0至9.0之间,对2-巯基乙醇等还原剂不敏感,且不存在于血小板或内皮细胞表面。用从硝酸纤维素膜上纯化的55 kDa抗原存在或不存在时患者外周血单个核细胞进行的[3H]胸腺嘧啶掺入试验表明,在13例循环抗55 kDa抗原抗体的患者中有6例出现特异性掺入,指数值范围为12至3。在17例未检测到血清抗55 kDa抗原抗体的患者中,也有3例观察到这种T细胞反应性。此外,抗原特异性T细胞反应性的指数值与一秒用力呼气量之间存在显著相关性(r = 0.544,p = 0.003)。我们的数据表明,检测此类抗体有助于根据严重程度区分哮喘患者亚组,并提示临床严重程度与T细胞和B细胞对55 kDa血小板/内皮细胞抗原的自身反应性之间的关系。